Smart Money · Holder IQ
71.7 / 100
Above median holder quality (percentile 91.7 this quarter). Tracked high-scoring holders are adding shares.
MANE
Veradermics, IncorporatedNYSE
$129.66-4.16%
Close Nov 13, 2026
Reading stored signals…
Healthcare • Biotechnology
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
- Market cap
- $5.47Bas of Nov 12, 2026
- 1 month
- +12.7%
- 3 months
- +19.8%
- 1 year
- —
More market facts
- Dividend
- No dividends on record
- Latest-quarter EPS estimate
- -$0.62Quarter ended Sep 30, 2026 · 6 analysts · -4.2% in 30d
- Short interest
- 10.5% of float3.4M shares · settled Oct 30, 2026 · -8.4% since Oct 15, 2026 · FINRA
Estimate history · same fiscal quarter
Quarter ended Sep 30, 2026. Source: Stored analyst estimates.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 6 analysts | -0.616 | — |
| 6 analysts | -0.616 | — |
| 5 analysts | -0.5972 | — |
| 5 analysts | -0.5913 | — |
| 5 analysts | -0.5913 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$92.68M
- Free cash flow
- -$78.33M
- Book value
- $813.61M
- Total debt
- $428K
- P/E
- —
- Price / sales
- —
- Price / book
- 6.7×
- FCF yield
- -1.4%
- Net margin
- —
Trailing twelve-month statements · as of Nov 13, 2026 · multiples on the Nov 12, 2026 market cap
End-of-day close from stored market data, not a live quote.
About Veradermics, Incorporated
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy.
Read more
Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.
- Website
- veradermics.com
- Headquarters
- New Haven, CT, United States
- Employees
- 37
- Listed
- Feb 4, 2026
- Fiscal year ends
- December
Company profile stored Oct 27, 2026.
Quarterly results
The last 7 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 11, 2026 | — | — | — | -$29.6M | -$23.5M |
| Mar 2026filed Mar 31, 2026 | — | — | — | -$29.9M | -$27.2M |
| Dec 2025filed Dec 31, 2025 | — | — | — | -$23.0M | -$21.8M |
| Sep 2025filed Sep 30, 2025 | — | — | — | -$20.3M | -$20.1M |
| Jun 2025filed Jun 30, 2025 | — | — | — | -$16.1M | -$15.6M |
| Mar 2025filed Mar 31, 2025 | — | — | — | -$12.9M | -$12.4M |
| Dec 2024filed Dec 31, 2024 | — | — | — | -$6.0M | -$5.7M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $319.3M
- Reported total debt
- $428.0K
- Current assets
- $824.7M
- Current liabilities
- $11.7M
Vendor filing date:
As of
- Reported cash
- $168.4M
- Current assets
- $397.1M
- Current liabilities
- $6.7M
Vendor filing date:
As of
- Reported cash
- $21.8M
- Reported total debt
- $4.0K
- Current assets
- $152.5M
- Current liabilities
- $9.2M
Vendor filing date:
As of
- Reported cash
- $5.7M
- Reported total debt
- $16.0K
- Current assets
- $18.7M
- Current liabilities
- $5.7M
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 3
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Dec 31, 2025 | — | — | — | -$72.3M | -$70.0M |
| Dec 2024filed Dec 31, 2024 | — | — | — | -$26.8M | -$26.5M |
| Dec 2023filed Dec 31, 2023 | — | — | — | -$17.3M | -$16.5M |
Annual cash generation
Does profit turn into cash? Compare MANE’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$70.0M
- Operating cash flow
- -$71.6M
- Capital spending
- $24.0K
- Free cash flow
- -$71.6M
Fiscal year ending
- Net income
- -$26.5M
- Operating cash flow
- -$23.7M
- Capital spending
- $0.0
- Free cash flow
- -$23.7M
Fiscal year ending
- Net income
- -$16.5M
- Operating cash flow
- -$13.5M
- Capital spending
- $0.0
- Free cash flow
- -$13.5M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did MANE’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $159.1M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $7.7M
- Total financing cash flow
- $60.5M
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $13.9M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 18 observations
Settlement Oct 30, 2026
3,389,250 shares short
-309,137 shares (-8.4%) vs Oct 15, 2026
10.5% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
3,698,387 shares short
-546,089 shares (-12.9%) vs Sep 30, 2026
11.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
4,244,476 shares short
+137,502 shares (+3.3%) vs Sep 15, 2026
13.1% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
4,106,974 shares short
+81,554 shares (+2%) vs Aug 31, 2026
15.1% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
4,025,420 shares short
+13,667 shares (+0.3%) vs Aug 14, 2026
14.8% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
4,011,753 shares short
-808,642 shares (-16.8%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
4,820,395 shares short
+884,047 shares (+22.5%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
3,936,348 shares short
+126,014 shares (+3.3%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
3,810,334 shares short
+1,317,639 shares (+52.9%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
2,492,695 shares short
+129,255 shares (+5.5%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
2,363,440 shares short
+313,258 shares (+15.3%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
2,050,182 shares short
-9,051 shares (-0.4%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
2,059,233 shares short
+268,909 shares (+15%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
1,790,324 shares short
-529,802 shares (-22.8%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
2,320,126 shares short
+923,182 shares (+66.1%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
1,396,944 shares short
+129,728 shares (+10.2%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
1,267,216 shares short
+233,168 shares (+22.5%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
1,034,048 shares short
Published Feb 25, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if MANE is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: MEDIUM
32 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Smart-money 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 1 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Largest 13-F holders · Q2 2026
164 filers reported a long position in MANE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
61.1%
of the 33.9M shares 13-F filers reported
Moves vs Q1 2026
7 added1 trimmed
2 unchanged
Net shares held
+28%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Montanova Capital, LLC | $512.5M · 4.2M shares | 4.2M | Unchanged |
| 2 | FMR LLC | $394M · 3.2M shares | 3.2M | +78.8% |
| 3 | SR One Capital Management, LP | $295.3M · 2.4M shares | 2.4M | Unchanged |
| 4 | Deep Track Capital, LP | $245.9M · 2M shares | 2M | +300% |
| 5 | Citadel Advisors LLC | $230.9M · 1.9M shares | 1.9M | +2.9% |
| 6 | Siren, L.L.C. | $203.5M · 1.7M shares | 1.7M | +10% |
| 7 | BlackRock, Inc. | $195.9M · 1.6M shares | 1.6M | +464% |
| 8 | Viking Global Investors LP | $192M · 1.6M shares | 1.6M | -7.6% |
| 9 | JPMorgan Chase & Co | $144.2M · 1.2M shares | 1.2M | +19.4% |
| 10 | Aberdeen Group plc | $134.8M · 1.1M shares | 1.1M | +4% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of MANE file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 13, 2026 | Longitude Capital Partners V, LLC13D · activist · amended | 9.8% |
| Oct 13, 2026 | JPMorgan Chase & Co13G · passive | 5.6% |
| Aug 21, 2026 | Montanova Capital, LLC13D · activist · amended | 8.8% |
| Aug 14, 2026 | SR One Capital Management LLC13D · activist · amended | 4.9%under 5% |
| Aug 6, 2026 | FMR LLC13G · passive | 7.6% |
| May 15, 2026 | Viking Global Investors LP13G · passive · amended | 4.5%under 5% |
| May 7, 2026 | Citadel Advisors LLC13G · passive | 4.5%under 5% |
| May 5, 2026 | Seven Fleet Capital Management LP13D · activist | 0.2%under 5% |
Moves the factor model did not explain
How much of MANE’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-14T15:32:53.526Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for MANE
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.